No abstract available
Keywords:
Immunohistochemistry (IHC); Metastatic prostate cancer; Neuroendocrine prostate cancer; Positron emission tomography/computed tomography (PET/CT) imaging; Prostate-specific membrane antigen.
Publication types
-
Case Reports
-
Comparative Study
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Aged
-
Antigens, Surface / metabolism*
-
Carcinoma, Neuroendocrine / diagnostic imaging*
-
Carcinoma, Neuroendocrine / genetics
-
Carcinoma, Neuroendocrine / metabolism
-
Glutamate Carboxypeptidase II / metabolism*
-
Humans
-
Lysine / administration & dosage
-
Lysine / analogs & derivatives*
-
Lysine / pharmacology
-
Male
-
Molecular Imaging
-
Mutation
-
Positron Emission Tomography Computed Tomography
-
Prostatic Neoplasms / diagnostic imaging*
-
Prostatic Neoplasms / genetics
-
Prostatic Neoplasms / metabolism
-
Retinoblastoma Binding Proteins / genetics
-
Tumor Suppressor Protein p53 / genetics
-
Ubiquitin-Protein Ligases / genetics
-
Urea / administration & dosage
-
Urea / analogs & derivatives*
-
Urea / pharmacology
Substances
-
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
-
Antigens, Surface
-
RB1 protein, human
-
Retinoblastoma Binding Proteins
-
TP53 protein, human
-
Tumor Suppressor Protein p53
-
Urea
-
Ubiquitin-Protein Ligases
-
FOLH1 protein, human
-
Glutamate Carboxypeptidase II
-
Lysine